IP Library Granted Patent US 10,327,955
Granted Patent B2
US 10,327,955 · App. 14/262,540 · Granted Jun 25, 2019

Absorbent article for application to human or animal skin surfaces

Inventor: Birgit Riesinger (Munster, DE)
Assignee: BSN medical GmbH
A61F13/00063A61F13/00008A61F13/00029A61F13/00068A61F13/069A61F2013/0054A61F2013/0074A61F2013/0091A61F2013/00157A61F2013/00229A61F2013/00519A61F2013/00748
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,327,955
App. No.
14/262,540
Granted
Jun 25, 2019
Kind
B2
Abstract

The invention relates to an absorbent article for application to human or animal skin surfaces in the region of wounds, consisting of an outer covering ( 2 ) which is permeable for liquid substances, and of an inner layer ( 1 ) which is surrounded by the covering ( 2 ) and which consists essentially of a mixture of an amount of strongly osmotically active substances with an amount of osmotically comparatively weak or osmotically inactive substances, such as cellulose. The inner layer ( 1 ) is filled with osmotically active substances in such a way that it is possible to exert on a wound, with the wound fluids contained therein, an osmotic pressure via which the wound fluid can be removed from the organism to be treated, and thus it is possible to assist both in the surfaced wound region and in the depth of the tissue a normal interstitial hydration of tissue by directing endogenous fluids in their direction of flow to the patient's skin surface into the absorbent article, and keeping them there.

Claims (26)

1. An absorbent article for application to human or animal skin surfaces in a region of a wound, the absorbent article comprising:

an outer covering comprising two layers which are liquid-permeable and which are joined together to form a pocket, said pocket being permeable to liquid substances; and

an inner layer in a form of a mat, said mat being located within said pocket and being freely movable within said pocket;

wherein the inner layer surrounded by the outer covering consists essentially of a mixture of an amount of strongly osmotically active substances which are superabsorbent particles of crosslinked, partially neutralized acrylic acid polymers, with an amount of osmotically weak or osmotically inactive substances, and

wherein more than 40% by weight of the mat comprises said osmotically active substances and is capable of functioning as a dressing for inhibition of harmful proteases.

2. The absorbent article according to claim 1 , wherein the inner layer is formed from an intermediate layer consisting of a mixture of superabsorbent polymers with cellulose as carrier material, and of two two-dimensional cover layers, or consists of hydrophilic fibers, and superabsorbent polymers with or without cellulose.

3. The absorbent article of claim 2 , wherein the hydrophilic fibers are carboxymethylcellulose fibers.

4. The absorbent article according to claim 1 , wherein inhibition of harmful proteases is inhibition by removing, absorbing and/or fixating harmful proteases.

5. The absorbent article according to claim 1 , wherein the harmful proteases are selected from a group consisting of matrix metallo proteases (MMPs) and tissue inhibitors of metallo proteases (TIMPs).

6. The absorbent article according to claim 1 , wherein the inner layer has a mass per unit area of at least 300 g/m 2 , with the mass per unit area of the proportion of osmotically active substances which is uniformly dispersed therein being at least 100 g/m 2 .

7. The absorbent article according to claim 1 , wherein the inner layer includes one or more osmotically active substances selected from a group consisting of salts, types of sugars, proteins and electrolytes.

8. The absorbent article according to claim 1 , wherein the inner layer leads to local immobilization of tissue-impairing proteases and growth-impairing proteases and factors transported by the wound exudate.

9. The absorbent article according to claim 1 , wherein the absorption capacity of the absorbent article is above a value which is about 95 g of water/100 cm 3 of the absorbent article measured as specified in DIN EN ISO 53923.

10. The absorbent article according to claim 1 , wherein the outer covering is adhesive for viscous, tacky, crosslinked or corpuscular substances which can thus be conveyed out of the wound when the absorbed article is changed.

11. The absorbent article according to claim 1 , wherein the inner layer is configured such that absorbed liquid is only released if the inner layer becomes completely saturated.

12. A method of treating harmful proteases in human or animal skin surfaces in a region of a wound, the method comprising steps of:

administering an absorbent article of claim 1 in a form of a dressing to the wound of a subject; and

inhibiting harmful proteases with the dressing.

13. The method of claim 12 , wherein the inner layer is formed from an intermediate layer consisting of a mixture of superabsorbent polymers with cellulose as carrier material, and of two two-dimensional cover layers, or consists of hydrophilic fibers, and superabsorbent polymers with or without cellulose.

14. The method of claim 13 , wherein the hydrophilic fibers are carboxymethylcellulose fibers.

15. The method according to claim 12 , wherein the step of inhibiting harmful proteases further comprises inhibiting at least one of matrix metallo proteases (MMPs) and tissue inhibitors of metallo proteases (TIMPs).

16. The method of claim 12 , wherein the inhibition of the harmful proteases is an inhibition by removing, absorbing and/or fixating harmful proteases.

17. The method of claim 12 , wherein the inner layer has a mass per unit area of at least 300 g/m 2 , with the mass per unit area of the proportion of osmotically active substances which is uniformly dispersed therein being at least 100 g/m 2 .

18. The method of claim 12 , wherein the outer covering has pores or meshes which are smaller than dimensions of substances to be absorbed in granule or powder form.

19. The method of claim 12 , wherein the inner layer leads to local immobilization of tissue-impairing proteases and growth-impairing proteases and factors transported by the wound exudate.

20. The method of according to claim 12 , wherein at least one detergent is added to the region of the wound as adjacent dressing material, which detergent brings about an increase in exudation of the wound.

Assignments (4)
MERGER Recorded Jul 12, 2017
From: BSN MEDICAL GMBH
To: BSN MEDICAL HOLDING GMBH
Reel/Frame 042982/0393 →
CHANGE OF NAME Recorded Jul 12, 2017
From: BSN MEDICAL HOLDING GMBH
To: BSN MEDICAL GMBH
Reel/Frame 043164/0268 →
MERGER AND CHANGE OF NAME Recorded May 3, 2016
From: BR ENTWICKLUNGS GMBH & CO. KG; BE BETEILIGUNGS GMBH
To: BSN MEDICAL GMBH
Reel/Frame 038447/0661 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 3, 2016
From: RIESINGER, BIRGIT
To: BR ENTWICKLUNGS GMBH & CO. KG
Reel/Frame 038598/0659 →
Priority Claims (1)
DE 20 2005 017211 · Nov 2, 2005 · national
Continuity (2)
Division 12091969
Related Publication 20140316353A1 · Oct 23, 2014